Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced movement disorders

F J Jiménez-Jiménez1, P J García-Ruiz, J A Molina

  • 1Department of Neurology, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.

Drug Safety
|March 1, 1997
PubMed
Summary

Many drugs can cause movement disorders like Parkinsonism and tardive dyskinesia. These drug-induced movement disorders are sometimes irreversible, even after medication cessation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First-generation merozoites of caprine <i>Eimeria christenseni</i> are capable to invade and egress primary host endothelial cells <i>in vitro</i>.

Frontiers in veterinary science·2025
Same author

[Cadmium polyneuropathy: a rare, but not less important, cause of peripheral neuropathy].

Revista de neurologia·2022
Same author

Cerebrospinal and blood levels of amino acids as potential biomarkers for Parkinson's disease: review and meta-analysis. Response to letter to the editor by Zheng et al.

European journal of neurology·2020
Same author

Cerebrospinal and blood levels of amino acids as potential biomarkers for Parkinson's disease: review and meta-analysis.

European journal of neurology·2020
Same author

[Myths and evidence on the use of botulinum toxin: neuropharmacology and dystonia].

Revista de neurologia·2018
Same author

[Amimia in Parkinson's disease. Significance and correlation with the clinical features].

Revista de neurologia·2018

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Drug-induced movement disorders (DIMDs) encompass a range of conditions including parkinsonism, tremor, chorea-ballismus, dystonia, tardive dyskinesia, myoclonus, tics, and akathisia.
  • Numerous medications are associated with the development of these movement disorders.

Purpose of the Study:

  • To review the spectrum of movement disorders that can be induced by various medications.
  • To identify the drug classes most commonly implicated in causing these adverse effects.

Main Methods:

  • Literature review of drug-induced movement disorders.
  • Analysis of drug classes frequently associated with movement abnormalities.

Main Results:

  • Antipsychotics, calcium antagonists, orthopramides, and substituted benzamides (e.g., metoclopramide, sulpiride) are among the most frequent culprits.
  • Central nervous system stimulants, antidepressants, anticonvulsants, antiparkinsonian drugs, and lithium also contribute to DIMDs.
  • A single drug may precipitate multiple types of movement disorders in a patient.

Conclusions:

  • A wide array of drugs can induce various movement disorders.
  • The potential for drug-induced movement disorders necessitates careful medication management and monitoring.
  • These movement disorders may not resolve even after the offending drug is discontinued.

Related Experiment Videos